Vanda Pharmaceuticals Announces Participation in the Mizuho Neuro & Ophthalmology Summit 2025

Rhea-AI Summary

Vanda Pharmaceuticals (Nasdaq: VNDA) announced its upcoming participation in investor meetings at the Mizuho Neuro & Ophthalmology Summit 2025. The event will take place in New York City on Wednesday, May 21, 2025. This conference provides an opportunity for Vanda to engage with investors and discuss their developments in the neurological and ophthalmological therapeutic areas.

News Market Reaction – VNDA

+3.61%

+3.61% Session move

In the trading session that priced this news, VNDA gained 3.61%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

WASHINGTON, May 16, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in investor meetings at the Mizuho Neuro & Ophthalmology Summit 2025 in New York City on Wednesday, May 21, 2025.

About Vanda Pharmaceuticals Inc.

Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on X @vandapharma.

Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com

Jim Golden / Jack Kelleher / Dan Moore
Collected Strategies
VANDA-CS@collectedstrategies.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-in-the-mizuho-neuro--ophthalmology-summit-2025-302458143.html

SOURCE Vanda Pharmaceuticals Inc.

FAQ

When is Vanda Pharmaceuticals (VNDA) participating in the Mizuho Neuro & Ophthalmology Summit 2025?

Vanda Pharmaceuticals will participate in investor meetings at the Mizuho Neuro & Ophthalmology Summit on Wednesday, May 21, 2025, in New York City.

Where is the Mizuho Neuro & Ophthalmology Summit 2025 being held?

The Mizuho Neuro & Ophthalmology Summit 2025 is being held in New York City.

What type of meetings will VNDA participate in at the Mizuho Summit 2025?

Vanda Pharmaceuticals will participate in investor meetings at the summit.

What is the stock symbol for Vanda Pharmaceuticals?

Vanda Pharmaceuticals trades on the Nasdaq under the symbol VNDA.